Skip to main content
Caplight Logo









Orthonika

Orthonika

Private
LondonHealthcare & Life Scienceshttps://orthonika.com

Last Round

Grant

May 31, 2023

Total Funding Raised

$3.23M

Company Overview

Orthonika operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in May 2023.

Orthonika is a medical technology company developing a synthetic total meniscus replacement implant to treat irreparable meniscus injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Orthonika Comparables

Compare Orthonika with similar companies based on industry and business-model similarity.

Orthonika comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ATRO Medical
93%
NUsurface
89%
Orteq Sports Medicine
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Orthonika Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 31, 2023
GrantMar 1, 2022
AngelMay 15, 2017
SeedAug 5, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Maria Kristina Bartolo

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Orthonika Investors

Notable investors and investment history

Orthonika investors
InvestorRounds
Imperial InnovationsSeed
Innovate UKGrant, Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 31, 2023

    $1.67M grant received from Innovate UK.

  • Mar 1, 2022

    $460K raised from Innovate UK.

Book a demo to see all signals

For institutional investors. Book with your work email.

Orthonika Filings

Explore SEC and related filing metadata, where available.

Orthonika filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Orthonika's valuation, stock price, and market status.

Is Orthonika a public or private company?

Orthonika is a private company.

What is the current stock price of Orthonika?

Orthonika is a private company, so its shares have no public market price. Caplight tracks Orthonika's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Orthonika worth (valuation)?

Valuation information for Orthonika is not publicly available.

Can I buy Orthonika stock?

Orthonika shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Orthonika's last funding round?

Orthonika's most recent funding round was Grant on May 31, 2023.

Who are the main investors in Orthonika?

Key investors in Orthonika include Imperial Innovations, Innovate UK.

Will Orthonika IPO soon?

No public IPO plans have been announced for Orthonika.

How can I track Orthonika secondary market activity?

Caplight tracks bids, offers, and trades in Orthonika's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range6
Year Founded2014
Last FundingMay 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?